Sangamo Therapeutics, Inc 10-K for FY2022
Sangamo Therapeutics, Inc (SGMOQ)
10-K
2023-02-23
For: 2022-12-31
View Original
Added on
April 10, 2026
About this 10-K
Sangamo Therapeutics, Inc filed this 10-K on February 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $111.3M
- up 0.5% from $110.7M a year earlier
- Net loss
- $192.28M
- compared with a net loss of $178.29M a year earlier
- Diluted EPS
- -$1.25
- compared with -$1.23 a year earlier